GeoVax Labs, Inc. (GOVX) Fair Value 2026

GOVX · Pharmaceutical Preparations ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.1 /10

32 fundamental signals · 8 models active

Value Trap Risk

LOW (33/100)

Quick Summary — As of 2026-07-15, GeoVax Labs, Inc. (GOVX) trades at $1.01, approximately 137% above CirclFi’s Bayesian DCF fair value of $0.43. QOC: 5.1/10. Value Trap Risk: 33/100 (LOW). 8/13 models active.

Key Facts

Ticker
GOVX
Price
$1.01
Quality Score
5.1/10
Value Trap Risk
33/100
Models Active
8/13
Last Updated
Strength: CUCE Ensemble suggests +78.8% upside with 2% confidence
Risk: Limited model coverage (8/13) may reduce confidence

Is GeoVax Labs, Inc. (GOVX) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, GeoVax Labs, Inc. (GOVX) appears undervalued as of : the median of 8 independent fair value estimates is $1.56, 54.6% above the current price of $1.01. Estimates range from $0.01 to $2.57. GOVX scores 5.1/10 on fundamental quality and 33/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy GeoVax Labs, Inc. Stock in 2026? →

Valuation Matrix

8 Intrinsic Value Models vs. Current Price ($1.01)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $0.43 -57.9%
CUCE Ensemble
Low Conviction
 $1.81 +78.8%
First Chicago
Medium Conviction
 $1.63 +61.5%
PWERM
Medium Conviction
 $1.36 +34.4%

Unlock the Full Matrix

Access 4 additional models including ML-RIV, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is GeoVax Labs, Inc. (GOVX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for GeoVax Labs, Inc.. Trading at $1.01 against an estimated intrinsic value of $1.38, 6 of 8 active models flag meaningful upside of +37.0% on average. The most optimistic model, FTNN, places fair value at $2.57 (+154.1%), while ML-RIV — the most conservative — estimates $0.01 (-98.8%). This +252.9% gap reflects genuine analytical uncertainty about GeoVax Labs, Inc.'s intrinsic worth.

What Do the Models Say About GOVX?

8 of 13 models are currently active for GOVX. Of these, 6 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates GOVX's intrinsic value at $0.43, implying -57.9% downside from the current price. See which stocks rank higher →

How Does GOVX Rank in Pharmaceutical Preparations?

Among 431 Pharmaceutical Preparations stocks, GOVX ranks #192 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.

See all Most Undervalued Pharmaceutical Preparations Stocks →

The Pharmaceutical Preparations sector introduces analytical considerations specific to pharmaceutical industry businesses. For GeoVax Labs, Inc., metrics like revenue per drug provide important context that general-purpose valuation models may underweight.

Is GOVX a Value Trap?

CirclFi's Value Trap algorithm assigns GOVX a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for GeoVax Labs, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, GeoVax Labs, Inc. scores 5.1 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +252.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every GOVX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across GOVX's 8 active models, average confidence is 18%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy GeoVax Labs, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Pharmaceutical Preparations Stocks Should You Also Analyze?

8 related Pharmaceutical Preparations stocks with 13-model coverage

AZNAstraZeneca PLCQOC 10.0CPRXCatalyst Pharmaceuticals, Inc.QOC 10.0HRMYHarmony Biosciences Holdings, IQOC 10.0NVONovo Nordisk A/SQOC 10.0SIGASIGA Technologies Inc.QOC 10.0UTHRUnited Therapeutics CorporationQOC 10.0ZTSZoetis Inc.QOC 10.0RDYDr. Reddy's Laboratories LtdQOC 9.9

Read investment analysis: AZN · CPRX · HRMY · NVO · SIGA

See all Pharmaceutical Preparations stocks ranked →

Frequently Asked Questions About GeoVax Labs, Inc.

What is GeoVax Labs, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, GeoVax Labs, Inc. (GOVX) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.43. The Quality of Company score is 5.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is GOVX overvalued or undervalued right now?

At $1.01, 6 of 8 active models suggest GOVX may be undervalued, while 2 indicate potential overvaluation. The median of all 8 fair value estimates is $1.56, 54.6% above the current price of $1.01 — a consensus view that GOVX is undervalued. The assessment depends on which methodology best fits GeoVax Labs, Inc.'s business model in Pharmaceutical Preparations.

What does a Quality of Company score of 5.1 mean for GOVX?

GeoVax Labs, Inc.'s QOC of 5.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on GOVX?

CirclFi analyzes GOVX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Is GOVX a value trap in 2026?

GeoVax Labs, Inc.'s Value Trap score is 33/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 8-model valuation engine, GeoVax Labs, Inc. (GOVX) has a median fair value of $1.56 — 54.6% above the current price of $1.01 — as of 2026-07-15.” Source: circlfi.com/stock/GOVX/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on GOVX.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access